GlassScriptPhysician profile
Rene L Johnson
NPI 1902120082
$760.25
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
See the full distribution for Obstetrics & Gynecology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $250 · 2022: $219 · 2023: $292.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $292.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $291.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $165.40 | 2021-2023 | |
| Aspira Women'S Health INC | $94.12 | 2021 | |
| Astellas Pharma US INC | $69.42 | 2023 | Myrbetriq, Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $66.50 | 2021-2022 | |
| Coopersurgical, INC. | $63.51 | 2022-2023 | Paragard T 380a |
| Daiichi Sankyo INC. | $40.00 | 2021-2023 | Injectafer |
| Merck Sharp & Dohme LLC | $39.57 | 2021-2023 | Gardasil 9 |
| Myovant Sciences INC. | $36.52 | 2021 | |
| Evofem Biosciences, INC. | $33.13 | 2021-2022 | |
| Exact Sciences Corporation | $23.16 | 2023 | Cologuard Collection Kit |
| Therapeuticsmd, INC. | $20.70 | 2022 | |
| Amgen INC. | $20.31 | 2022 | |
| Mylan Pharmaceuticals INC. | $19.45 | 2022 | |
| Organon LLC | $19.42 | 2021-2022 | |
| Exeltis, USA INC. | $19.39 | 2023 | Slynd |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $16.57 | 2021 | |
| Novo Nordisk INC | $13.08 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rene Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.